Schoenherr Thomas Edward 4

What Happened
Thomas Edward Schoenherr, CEO of Diagnostics at Tempus AI (TEM), was granted 13,642 restricted stock units (RSUs) on May 4, 2026. The Form 4 reports an acquisition price of $0.00 (award/grant). Of the 13,642 RSUs, 3,642 are fully vested and 10,000 are subject to a vesting schedule (see below).

Key Details

• Transaction date: May 4, 2026; Form 4 filed May 6, 2026 (accession 0002113721-26-000004).
• Transaction type/code: Award/Grant (A); reported acquisition amount: 13,642 RSUs at $0.00.
• Vesting: 3,642 RSUs fully vested; 10,000 RSUs vest in eight equal quarterly installments commencing November 15, 2026 (1,250 RSUs per quarter).
• Shares owned after transaction: Not specified in the provided filing.
• No 10b5‑1 plan, tax‑withholding sale, or late‑filing indication was noted in the data provided.

Context
RSU grants are a form of compensation; vested RSUs convert to company shares (or net‑settled share equivalents) and represent immediate equity, while the 10,000 time‑vested RSUs will convert to shares as they vest over the specified quarters. Awards do not necessarily signal insider buying or selling intent — they are routine compensation disclosures and their ultimate value depends on TEM’s future stock price.